(IN BRIEF) AstraZeneca has secured FDA approval for a new subcutaneous autoinjector version of Saphnelo, enabling once-weekly self-administration for adults with systemic lupus erythematosus. The approval is based on Phase III trial results showing significant reductions in disease activity compared … Read the full press release
Posted in Business, Financial, Government, Healthcare, Industrial, Investment, Management, Marketing, Pharma & Biotech, Science, Security & Safety, Technology, United Kingdom
Tagged anifrolumab, AstraZeneca, AstraZeneca introduces new subcutaneous Saphnelo delivery method to improve convenience and outcomes in lupus care, autoimmune disease, autoinjector, biologic therapy, Bristol-Myers Squibb, clinical trials, FDA, Healthcare Innovation, Louise Vetter, Lupus Foundation of America, Medarex, Ruud Dobber, Saphnelo, SLE, Susan Manzi, systemic lupus erythematosus, TULIP-SC, U.S. Food and Drug Administration
(IN BRIEF) Gerresheimer has launched Gx InMonit, a smart add-on device for autoinjectors, along with Gx AdheraLink, an AI-driven messaging solution, to improve patient adherence to home-based injection therapies. The system guides patients through the injection process, captures real-time data, … Read the full press release
Posted in Artificial Intelligence (AI), Germany, Healthcare, Pharma & Biotech, Technology
Tagged AI messaging, autoinjector, Centor, digital health, Gerresheimer, Gerresheimer Introduces Smart Injection Support Ecosystem to Improve Patient Adherence and Therapy Outcomes, Gerresheimer Launches Gx InMonit and AI Driven AdheraLink to Transform Home Based Injection Therapy Management, Gx AdheraLink, Gx Inbeneo, Gx InMonit, Healthcare Innovation, home therapy, Mithun Ratnakumar, NFC, patient adherence, pharmaceutical technology, remote monitoring, RxCap
(IN BRIEF) SCHOTT Pharma has launched the industry’s first 5.5 ml prefillable staked-needle glass syringe, expanding its syriQ BioPure® platform to support biologic therapies designed for home administration. The syringe integrates seamlessly with Ypsomed’s YpsoMate® 5.5 ml autoinjector and Datwyler’s … Read the full press release
Posted in Business, Germany, Healthcare, Industrial, News, Pharma & Biotech, Science, Technology
Tagged Andreas Reisse, autoinjector, biologic therapies, biopharmaceuticals, chronic disease treatment, CPHI Frankfurt, Datwyler, drug delivery, glass syringe, Healthcare Innovation, homecare, large-volume injector, medical technology, patient care, pharmaceutical innovation, SCHOTT Pharma, SCHOTT Pharma and Ypsomed drive innovation in large-volume injectable drug delivery with new 5.5 ml syringe, SCHOTT Pharma unveils 5.5 ml BioPure glass syringe to advance home-based biologic treatments, Subcutaneous Injection, syriQ BioPure, tungsten-free syringe, Ulrike Bauer, YpsoMate, Ypsomed
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?